Advanced search
Publication Cover
International Journal of Hematologic Oncology Volume 12, 2023 - Issue 1
Journal homepage
1,209
Views
0
CrossRef citations to date
0
Altmetric
Preliminary Communication

Improved Survival of Adolescents and Young Adults Patients with T-Cell Acute Lymphoblastic Leukemia

Amr Hanbali1 Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi ArabiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0208-0713
ORCID Icon,
Ahmed Kotb2 Department of Medicine, Hematology unit, Zagazig University, Egypt
,
Riad El Fakih1 Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
,
Feras Alfraih1 Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
,
Nahla Shihata3 King Faisal Specialist Hospital, Jeddah, Saudi Arabia
,
Walid Rasheed1 Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
,
Syed Osman Ahmed1 Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
,
Marwan Shaheen1 Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
,
Saud Alhayli1 Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
,
Ali Alahmari1 Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
,
Ahmad Alotaibi1 Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
,
Alfadel Alshaibani1 Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
,
Abdulwahab Albabtain1 Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
,
Mansour Alfayez1 Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
,
Maha Hassan1 Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
,
Fahad Alsharif1 Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
,
Naeem Chaudhri1 Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
,
Fahad Almohareb1 Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
,
Hazzaa Alzahrani1 Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
&
Mahmoud Aljurf1 Division of Hematology, Stem cell transplantation & Cellular therapy, Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
 show all
Article: IJH42 | Received 14 Sep 2022, Accepted 30 Jan 2023, Published online: 28 Feb 2023

References

  • DoresGM, DevesaSS, CurtisRE, LinetMS, MortonLM. Acute leukemia incidence and patient survival among children and adults in the United States, 2001–2007. Blood 119(1), 34–43 (2012).
  • HarrisonCJ. Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia. Br. J. Haematol. 144(2), 147–156 (2009).
  • BakrM, RasheedW, MohamedSYet al. Allogeneic hematopoietic stem cell transplantation in adolescent and adult patients with high-risk T cell acute lymphoblastic leukemia. Biol. Blood Marrow Transplant. 18(12), 1897–1904 (2012).
  • JainN, LambAV, O’brienSet al. Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype. Blood 127(15), 1863–1869 (2016).
  • KozlowskiP, ÅströmM, AhlbergLet al. High relapse rate of T cell acute lymphoblastic leukemia in adults treated with hyper‐CVAD chemotherapy in Sweden. Eur. J. Haematol. 92(5), 377–381 (2014).
  • YanadaM, JinnaiI, TakeuchiJet al. Clinical features and outcome of T-lineage acute lymphoblastic leukemia in adults: a low initial white blood cell count, as well as a high count predict decreased survival rates. Leuk. Res. 31(7), 907–914 (2007).
  • HuguetF, LeguayT, RaffouxEet al. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. J. Clin. Oncol. 27(6), 911–918 (2009).
  • MakadyA, DeBoer A, HillegeH, KlungelO, GoettschW. What is real-world data? A review of definitions based on literature and stakeholder interviews. Value Health 20(7), 858–865 (2017).
  • AvramisVI, SencerS, PericlouAPet al. A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children’s Cancer Group study. Blood 99(6), 1986–1994 (2002).
  • HanbaliA, KotbA, ElFakih Ret al. Improved survival in adolescents and young adults (AYA) patients aged 14–55 years with acute lymphoblastic leukemia using pediatric-inspired protocol–a retrospective analysis of a real-world experience in 79 of patients treated at a national tertiary care referral center. Leuk. Res. Rep. 16, 100270 (2021).
  • AljurfM, ZaidiSZ. Chemotherapy and hematopoietic stem cell transplantation for adult T-cell lymphoblastic lymphoma: current status and controversies. Biol. Blood Marrow Transplant. 11(10), 739–754 (2005).
  • RamanujacharR, RichardsS, HannIet al. Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials. Pediatr. Blood Cancer 48(3), 254–261 (2007).
  • BoisselN, AuclercM-F, LhéritierVet al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J. Clin. Oncol. 21(5), 774–780 (2003).
  • DeBont J, VanDer Holt B, DekkerA, SonneveldP, PietersR. Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands. Leukemia 18(12), 2032–2035 (2004).
  • StockW, LugerSM, AdvaniASet al. A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10.03. Blood 133(14), 1548–1559 (2019).
  • MufflyL, CurranE. Pediatric-inspired protocols in adult acute lymphoblastic leukemia: are the results bearing fruit?Hematology Am. Soc. Hematol. Educ. Program 2019(1), 17–23 (2019).
  • SiegelSE, StockW, JohnsonRHet al. Pediatric-inspired treatment regimens for adolescents and young adults with philadelphia chromosome–negative acute lymphoblastic leukemia: a review. JAMA Oncol. 4(5), 725–734 (2018).
  • SawyerSM, AzzopardiPS, WickremarathneD, PattonGC. The age of adolescence… and young adulthood–Authors’ reply. Lancet Child Adolesc. Health 2(4), e7 (2018).
  • InabaH, PuiC-H. Glucocorticoid use in acute lymphoblastic leukaemia. Lancet Oncol. 11(11), 1096–1106 (2010).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.